Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear
Primary Purpose
Astigmatism
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
senofilcon A toric
alphafilcon A toric
Sponsored by
About this trial
This is an interventional treatment trial for Astigmatism focused on measuring Astigmatism, vision, comfort, satisfaction, contact lenses
Eligibility Criteria
Inclusion Criteria: Prior to being considered eligible to participate in this study, subjects MUST
- be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
- be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy.
- have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
- be able and willing to adhere to the instructions set forth in the protocol.
- agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
- have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
- have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
- be in good general health, based on his/her knowledge.
- read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.
Exclusion Criteria:
- The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
- The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
- The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
Slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Pterygium or corneal scars within the visual axis
- Neovascularization >1mm in from the limbus
- History of giant papillary conjunctivitis (GPC) worse than Grade 2
- Anterior uveitis or iritis (past or present)
- Seborrhoeic eczema, seborrhoeic conjunctivitis
- A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
- A known history of corneal hypoesthesia (reduced corneal sensitivity.)
- Aphakia, keratoconus or a highly irregular cornea.
- Current pregnancy or lactation (to the best of the subject's knowledge).
- Active participation in another clinical study at any time during this study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
senofilcon A toric / alphafilcon A toric
alphafilcon A toric / senofilcon A toric
Arm Description
senofilcon A toric contact lenses worn daily during the first period, then alphafilcon A toric contact lenses worn daily during the second period
alphafilcon A toric contact lenses worn daily during the first period, then senofilcon A toric contact lenses worn daily during the second period
Outcomes
Primary Outcome Measures
Subjective Reported Vision
A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score >0 then greater vision, if <0 then lesser vision.
Subject Reported Lens Comfort.
A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is >0 indicates comfortable and <0 indicates uncomfortable.
Secondary Outcome Measures
Full Information
NCT ID
NCT00584220
First Posted
December 20, 2007
Last Updated
May 5, 2015
Sponsor
Johnson & Johnson Vision Care, Inc.
Collaborators
Foresight Regulatory Strategies, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00584220
Brief Title
Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear
Official Title
Evaluation of Fit and Visual Acuity of the Investigational Toric Lens in Two Phases: Part B: A Dispensing Cross-over Comparison to SofLens66 Toric
Study Type
Interventional
2. Study Status
Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
September 2007 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
December 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Johnson & Johnson Vision Care, Inc.
Collaborators
Foresight Regulatory Strategies, Inc.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric contact lens currently available in market, specifically with regards to the comfort and vision after two weeks of use.
Detailed Description
Dispensing, single-masked (subject-masked), randomized, 2-visit controlled study of two-weeks duration.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Astigmatism
Keywords
Astigmatism, vision, comfort, satisfaction, contact lenses
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
96 (Actual)
8. Arms, Groups, and Interventions
Arm Title
senofilcon A toric / alphafilcon A toric
Arm Type
Other
Arm Description
senofilcon A toric contact lenses worn daily during the first period, then alphafilcon A toric contact lenses worn daily during the second period
Arm Title
alphafilcon A toric / senofilcon A toric
Arm Type
Other
Arm Description
alphafilcon A toric contact lenses worn daily during the first period, then senofilcon A toric contact lenses worn daily during the second period
Intervention Type
Device
Intervention Name(s)
senofilcon A toric
Intervention Description
contact lens
Intervention Type
Device
Intervention Name(s)
alphafilcon A toric
Other Intervention Name(s)
SofLens66 Toric
Intervention Description
contact lens
Primary Outcome Measure Information:
Title
Subjective Reported Vision
Description
A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score >0 then greater vision, if <0 then lesser vision.
Time Frame
1 week
Title
Subject Reported Lens Comfort.
Description
A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is >0 indicates comfortable and <0 indicates uncomfortable.
Time Frame
1 week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Prior to being considered eligible to participate in this study, subjects MUST
be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy.
have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
be able and willing to adhere to the instructions set forth in the protocol.
agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
be in good general health, based on his/her knowledge.
read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.
Exclusion Criteria:
The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
Slit lamp findings that would contraindicate contact lens wear such as:
Pathological dry eye or associated findings
Pterygium or corneal scars within the visual axis
Neovascularization >1mm in from the limbus
History of giant papillary conjunctivitis (GPC) worse than Grade 2
Anterior uveitis or iritis (past or present)
Seborrhoeic eczema, seborrhoeic conjunctivitis
A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
A known history of corneal hypoesthesia (reduced corneal sensitivity.)
Aphakia, keratoconus or a highly irregular cornea.
Current pregnancy or lactation (to the best of the subject's knowledge).
Active participation in another clinical study at any time during this study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jason Chin, O.D.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
James Fujimoto, O.D.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Weslie Hamada, O.D.
Organizational Affiliation
Arthur T. Kobayashi, O.D., Inc.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dennis Kuwuabara, O.D.
Organizational Affiliation
Eye Care Associates of Hawaii
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mark Nakano, O.D.
Organizational Affiliation
Mark E. Nakano Optometric Corp.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ikuko Sugimoto, O.D.
Organizational Affiliation
Unaffilliated
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kevin Rosin, O.D.
Organizational Affiliation
Drs. Farkas, Kassalow, Resnick & Associates
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jennifer Kao, O.D.
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear
We'll reach out to this number within 24 hrs